Patents by Inventor Yuma ISHIDA

Yuma ISHIDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11917917
    Abstract: A thermoelectric conversion element that has a power generation layer containing an iron-aluminum based magnetic alloy material containing equal to or more than 70 weight percent of iron and aluminum in total. The power generation layer generates an electromotive force, due to an anomalous Nernst effect that develops in the magnetic alloy material in response to a temperature gradient applied thereto, in a direction intersecting both the magnetization direction of the magnetic alloy material and the direction of the applied temperature gradient.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: February 27, 2024
    Assignee: NEC CORPORATION
    Inventors: Akihiro Kirihara, Yasutomo Omori, Ryohto Sawada, Masahiko Ishida, Koichi Terashima, Yuma Iwasaki, Hiroko Someya
  • Patent number: 11725002
    Abstract: A detection reagent for comprehensively detecting an oxidized state and a glycated state of a low-density lipoprotein. While an oxidized low-density lipoprotein and a glycated low-density lipoprotein are detected with a fluolophore-labelled antibody, a lipid radical is detected with a fluorescent nitroxide 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperadine-1-oxyl (NBD-Pen).
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: August 15, 2023
    Assignees: FUSO PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Ken-ichi Yamada, Tomomi Ide, Yuma Ishida, Go Ichien, Keiichi Yamamoto
  • Publication number: 20200140426
    Abstract: A detection reagent for comprehensively detecting an oxidized state and a glycated state of a low-density lipoprotein. While an oxidized low-density lipoprotein and a glycated low-density lipoprotein are detected with a fluolophore-labelled antibody, a lipid radical is detected with a fluorescent nitroxide 2,2,6-trimethyl-4-(4-nitrobenzo[1,2,5]oxadiazol-7-ylamino)-6-pentylpiperadine-1-oxyl (NBD-Pen).
    Type: Application
    Filed: April 27, 2018
    Publication date: May 7, 2020
    Inventors: Ken-ichi YAMADA, Tomomi IDE, Yuma ISHIDA, Go ICHIEN, Keiichi YAMAMOTO